Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
about
Single vs. combination immunotherapeutic strategies for glioma.Experimental approaches for the treatment of malignant gliomas.Immunotherapy of brain cancers: the past, the present, and future directions.Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.Gene therapy for malignant glioma.Use of suicide genes for cancer gene therapy: study of the different approaches.Cytokine gene therapy for malignant glioma.Immunotherapy for malignant glioma: current approaches and future directions.Current immunotherapeutic strategies for central nervous system tumors.Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasStereotactic radiosurgery: adjacent tissue injury and response after high-dose single fraction radiation. Part II: Strategies for therapeutic enhancement, brain injury mitigation, and brain injury repair.Recent advances and future of immunotherapy for glioblastoma.Gene therapy for high-grade glioma: current approaches and future directions.Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.Cellular immunotherapy for malignant gliomas.Production of recombinant adenovirus containing human interlukin-4 gene.Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits.Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression oEffective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.Immunotherapy for brain tumors: quo vadis?The characterization of tumor apoptosis after experimental radiosurgery.
P2860
Q33746041-E7E985AF-E917-4C0E-9994-44A6A8AF5DB5Q34127138-59260967-5429-40BA-ABB6-B777DCCBEC0AQ34701587-513FD2AE-832D-4F66-9BDE-F1F13AA1E2ECQ35051285-8C2121C5-C3DD-47AE-9F9C-BF85B87635C1Q35673628-F6972AFF-7038-435D-ABF5-DF0FFC53FF96Q35753524-3BA7AAA2-F3C5-43C7-909D-1D16C5879F49Q35907022-FD29FD04-7038-4F4D-998F-1D02BCE69C0FQ36273693-2DE0A6C3-9856-4D22-8B43-274A42D8489FQ36325239-F4A4317C-6262-40D3-8306-ED64B85DC149Q36478070-511DAB9F-0750-426D-B59E-CEADE909D326Q36802285-FBFEEFC2-BDE0-498F-AFA3-269DEFEDD898Q37239071-21A43729-CAF8-4ADD-87A7-638F72A3AE21Q37406685-0E4784B5-7DA8-45B6-9CE1-019A445AC729Q37818222-64C1D505-DCCF-419B-83CC-1C2C1EC0E799Q38902169-58F1B8FD-002A-4E52-AF56-D97A84FAD70FQ39451439-E6076C92-BA38-44E2-B795-F592443D57E4Q40445765-FC7B9488-0DC8-4B8D-9006-9C3A695E5CDEQ40464370-515E0FDE-6580-4D50-A970-F5EEC2378688Q40485606-21D7ED99-8C16-4178-9B1F-066A4E279BC2Q43115465-EA817C2E-A515-4FF7-8406-560F79704B52Q43747174-8BB7912C-16E7-429B-9433-BA5BC20EBC9BQ44059979-BEF5160E-08D8-441F-A33F-7EEB4A4EFB44Q44393120-1B8879AC-3C68-40C4-AC0B-C3A957D02C1FQ45858439-AC4BCCBA-32A4-410D-B600-7C3D86819D96Q45871910-F8F1C94C-8CD0-4753-8EDA-E7AC720B7B8FQ45879265-5D984211-C351-4E89-8CD9-2ECB20D3FF98Q46039988-D695F0E8-C065-4B41-9D3B-68C3F52E66A2Q47794847-19861B02-3FB4-4634-86C4-E062E36417BFQ48579421-991661E5-FFDE-44F7-B7D2-C176B3EA2747Q48962259-37C73C05-88E8-4AB8-9921-6CD696F5B362
P2860
Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@en
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@nl
type
label
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@en
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@nl
prefLabel
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@en
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@nl
P2093
P2860
P356
P1433
P1476
Effective cytokine gene therap ...... IL-4 plus HSVtk tumor vaccine.
@en
P2093
Attanucci J
Chambers WH
Fellows WK
Giezeman-Smits KM
P2860
P2888
P304
P356
10.1038/SJ.GT.3300798
P577
1999-02-01T00:00:00Z
P5875
P6179
1050737985